Nymox Pharmaceutical Corp
NYMXF- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001018735
No open-market purchases or sales by Nymox Pharmaceutical Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4.21K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Nymox Pharmaceutical Corp as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +5 vs. Q3 2021
- Shares held
- 1.57M
- −368.8K (−19.0%) vs. Q3 2021
- Total value
- $2.05M
- −$1.95M (−48.8%) vs. Q3 2021
- New holders
- 9
- 5 more added
- Sold out
- 4
- 18 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYMXF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4.21K |
| Q1 2026 | 1 | $2.46K |
| Q4 2025 | 1 | $1.41K |
| Q3 2025 | 1 | $2.06K |
| Q2 2025 | 1 | $4.13K |
| Q1 2025 | 2 | $16.0K |
| Q4 2024 | 1 | $3.51K |
| Q3 2024 | 2 | $13.2K |
| Q2 2024 | 1 | $6.67K |
| Q1 2024 | 3 | $48.0K |
| Q4 2023 | 2 | $26.6K |
| Q3 2023 | 5 | $68.3K |
| Q2 2023 | 36 | $287.4K |
| Q1 2023 | 35 | $575.1K |
| Q4 2022 | 37 | $443.7K |
| Q3 2022 | 34 | $494.6K |
| Q2 2022 | 39 | $590.1K |
| Q1 2022 | 40 | $2.25M |
| Q4 2021 | 43 | $2.05M |
| Q3 2021 | 38 | $4.00M |
| Q2 2021 | 51 | $4.03M |
| Q1 2021 | 59 | $13.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Nymox Pharmaceutical Corp; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 167 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 200 | $0 | 0.00% | +200 | New |
| Snowden Capital Advisors LLC | 675 | $0 | 0.00% | +675 | New |
| Steward Financial Group LLC | 100 | $0 | 0.00% | +100 | New |
| Group One Trading, L.P. | 596 | $1.00K | 0.00% | −21,433−97.3% | Reduced |
| UBS Group AG | 550 | $1.00K | 0.00% | −2,783−83.5% | Reduced |
| Rockefeller Capital Management L.P. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 1,700 | $2.21K | 0.00% | +3+0.2% | Added |
| Sterling Investment Advisors, Ltd. | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Cornerstone Advisory, LLC | 4,536 | $6.00K | 0.00% | +4,536 | New |
| Advisor Group Holdings, Inc. | 8,000 | $10.0K | 0.00% | −4,100−33.9% | Reduced |
| Wells Fargo & Company | 7,478 | $10.0K | 0.00% | 00.0% | Unchanged |
| PSI Advisors, LLC | 8,000 | $10.0K | 0.00% | +5,000+166.7% | Added |
| Tower Research Capital LLC (TRC) | 8,417 | $11.0K | 0.00% | +8,417 | New |
| One Day In July LLC | 10,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 6,109 | $13.0K | 0.00% | 00.0% | Unchanged |
| Lincoln National Corp | 10,315 | $13.0K | 0.00% | +10,315 | New |
| Susquehanna Fundamental Investments, LLC | 11,444 | $15.0K | 0.00% | −2,056−15.2% | Reduced |
| JPMorgan Chase & Co | 12,081 | $15.0K | 0.00% | −99−0.8% | Reduced |
| Kestra Advisory Services, LLC | 11,532 | $15.0K | 0.00% | 00.0% | Unchanged |
| Veriti Management LLC | 11,315 | $15.0K | 0.00% | +11,315 | New |
| Cubic Asset Management, LLC | 14,000 | $18.0K | 0.00% | +900+6.9% | Added |
| Bank of America Corp | 15,117 | $20.0K | 0.00% | −7,166−32.2% | Reduced |
| Simplex Trading, LLC | 16,386 | $21.0K | 0.00% | +9,008+122.1% | Added |
| National Bank of Canada | 17,200 | $22.0K | 0.00% | +17,200 | New |
| Willow Creek Wealth Management Inc. | 18,724 | $24.0K | 0.00% | −5,500−22.7% | Reduced |
| Millennium Management LLC | 21,880 | $28.0K | 0.00% | −46,743−68.1% | Reduced |
| Patriot Financial Group Insurance Agency, LLC | 23,400 | $30.0K | 0.00% | −8,000−25.5% | Reduced |
| Goldman Sachs Group Inc | 24,382 | $32.0K | 0.00% | +10.0% | Added |
| Gofen & Glossberg LLC | 25,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 25,658 | $33.0K | 0.00% | +25,658 | New |
| Brown Advisory Securities, LLC | 28,000 | $36.0K | 0.02% | 00.0% | Unchanged |
| Credit Suisse AG | 30,000 | $39.0K | 0.00% | −140.0% | Reduced |
| First Citizens Financial Corp | 35,100 | $46.0K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 50,678 | $65.0K | 0.00% | −53−0.1% | Reduced |
| Susquehanna International Group, LLP | 65,988 | $86.0K | 0.00% | −24,051−26.7% | Reduced |
| Morgan Stanley | 67,100 | $87.0K | 0.00% | −3,517−5.0% | Reduced |
| Leonteq Securities AG | 74,999 | $97.5K | 0.00% | −4,998−6.2% | Reduced |
| Webster Bank, N. A. | 80,000 | $104.0K | 0.01% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 85,100 | $111.0K | 0.00% | −85,100−50.0% | Reduced |
| Ergoteles LLC | 101,332 | $132.0K | 0.01% | −83,601−45.2% | Reduced |
| BlackRock Inc. | 135,660 | $176.0K | 0.00% | −2,008−1.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 501,000 | $651.3K | 0.01% | −20,000−3.8% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −114,635−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −5,046−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |